ProCE Banner Activity

CE / CME

Pharmacotherapies for Psychiatric Disorders: What Does the Future Hold?

Multimedia
Listen to one of the world’s leading experts discuss the future of pharmacotherapies for psychiatric disorders.

Pharmacists : 1.25 contact {hours} ({0.125} CEUs)

Physicians : maximum of 1.25 AMA PRA Category 1 {Credits}

Physician Assistants : maximum of 1.25 {hours} of AAPA Category I (Preapproved) {credits}

Released: March 15, 2020

Expiration: March 15, 2021

No longer available for credit.

Share

Faculty

Greg W. Mattingly

Greg W. Mattingly, MD

Associate Clinical Professor
Washington University
President
Midwest Research Group
President Elect
American Professional Society for ADHD and Related Disorders
St. Louis, Missouri

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

Neurocrine Biosciences

Sunovion

Takeda

Tris Pharmaceuticals

Partners

GME

ProCE Banner

Faculty Disclosure

Primary Author

Greg W. Mattingly, MD

Associate Clinical Professor
Washington University
President
Midwest Research Group
President Elect
American Professional Society for ADHD and Related Disorders
St. Louis, Missouri

Additional Information

Program Medium

This program has been made available online.